Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Sunday, April 27, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
admin
-
April 11, 2025
Latest Pharma-News
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
admin
-
April 9, 2025
Latest Pharma-News
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
admin
-
April 9, 2025
Latest Pharma-News
AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025
admin
-
April 9, 2025
Latest Pharma-News
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices
admin
-
February 10, 2025
Latest Pharma-News
Bayer and Cat Creek Energy Sign Landmark Renewable Energy Deal
admin
-
May 4, 2023
0
Latest Pharma-News
Sandoz to exclusively commercialize six products in the US, reinforcing global leadership position in off-patent medicines
admin
-
May 4, 2023
0
Latest Pharma-News
XTANDI® plus Leuprolide Reduced the Risk of Metastasis by 58% in Non-Metastatic Hormone-Sensitive Prostate Cancer versus Placebo plus Leuprolide
admin
-
April 30, 2023
0
Latest Pharma-News
Update on FDA Advisory Committee vote on Lynparza plus abiraterone for metastatic castration-resistant prostate cancer
admin
-
April 30, 2023
0
Latest Pharma-News
EMA validates marketing authorisation application for Jemperli plus chemotherapy for dMMR/MSI-H primary advanced or recurrent endometrial cancer
admin
-
April 25, 2023
0
Latest Pharma-News
FDA Authorizes Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines
admin
-
April 21, 2023
0
Latest Pharma-News
Bayer’s New data from pivotal studies with aflibercept 8 mg
admin
-
April 21, 2023
0
Latest Pharma-News
FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation
admin
-
April 19, 2023
0
Latest Pharma-News
Update to contractual arrangements between AstraZeneca, Swedish Orphan Biovitrum AB and Sanofi
admin
-
April 11, 2023
0
Latest Pharma-News
FDA Accepts Pfizer’s sNDA for BRAFTOVI + MEKTOVI
admin
-
April 10, 2023
0
Latest Pharma-News
Sandoz receives approval by EC for Hyrimoz® high-concentration formulation
admin
-
April 6, 2023
0
Latest Pharma-News
AZ’s Lynparza and Imfinzi combination shows positive results in advanced ovarian cancer
admin
-
April 6, 2023
0
1
2
3
4
...
145
Page 3 of 145
- Advertisment -
Most Read
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
April 11, 2025
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
April 9, 2025
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
April 9, 2025
AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025
April 9, 2025